William Scott III

William Scott III


Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 December 2022 in Nature
Verified
Journal Article
Open access
PDF file
TBTeresa Brevini
Teresa Brevini
MMMailis Maes
Mailis Maes
GWGwilym J. Webb
Gwilym J. Webb
BJBinu V. John
Binu V. John
CFClaudia D. Fuchs
Claudia D. Fuchs
FSFotios Sampaziotis
Fotios Sampaziotis
Preventing SARS-CoV-2 infection by modulating viral host receptors, such as angiotensin-converting enzyme 2 (ACE2)1, could represent a new chemoprophylactic approach for COVID-19 that complements vaccination2,3. However, the mechanisms that control the expression of ACE2 remain unclear. Here we show that the farnesoid X receptor (FXR) is a direct regulator of ACE2 transcription in several tissues affected by COVID-19, including the gastrointestinal and respiratory systems. We then use the over-the-counter compound z-guggulsterone and the off-patent drug ursodeoxycholic acid (UDCA) to reduce FXR signalling and downregulate ACE2 in human lung, cholangiocyte and intestinal organoids and in the corresponding tissues in mice and hamsters. We show that the UDCA-mediated downregulation of ACE2 reduces susceptibility to SARS-CoV-2 infection in vitro, in vivo and in human lungs and livers perfused ex situ. Furthermore, we reveal that UDCA reduces the expression of ACE2 in the nasal epithelium in humans. Finally, we identify a correlation between UDCA treatment and positive clinical outcomes after SARS-CoV-2 infection using retrospective registry data, and confirm these findings in an independent validation cohort of recipients of liver transplants. In conclusion, we show that FXR has a role in controlling ACE2 expression and provide evidence that modulation of this pathway could be beneficial for reducing SARS-CoV-2 infection, paving the way for future clinical trials.

1 October 2018 in Materials Science and Engineering: C
Verified
Journal Article
Open access
Giorgia MontalbanoGiorgia Montalbano
Giorgia Montalbano
STS. Toumpaniari
S. Toumpaniari
APAlexander Popov
Alexander Popov
PDP. Duan
P. Duan
JCJ. Chen
J. Chen
AFAna Marina Ferreira
Ana Marina Ferreira
Hydrogels based on natural polymers offer a range of properties to mimic the native extracellular matrix, and provide microenvironments to preserve cellular function and encourage tissue formation. A tri-component hydrogel using collagen, alginate and fibrin (CAF) was developed and investigated at three collagen concentrations for application as a functional extracellular matrix analogue. Physical-chemical characterization of CAF hydrogels demonstrated a thermo-responsive crosslinking capacity at physiological conditions with stiffness similar to native soft tissues. CAF hydrogels were also assessed for cytocompatibility using L929 murine fibroblasts, pancreatic MIN6 β-cells and human mesenchymal stem cells (hMSCs); and demonstrated good cell viability, proliferation and metabolic activity after 7 days of in vitro culture. CAF hydrogels, especially with 2.5% w/v collagen, increased alkaline phosphatase production in hMSCs indicating potential for the promotion of osteogenic activity. Moreover, CAF hydrogels also increased metabolic activity of MIN6 β-cells and promoted the reconstitution of spherical pseudoislets with sizes ranging between 50 and 150 μm at day 7, demonstrating potential in diabetic therapeutic applications.

15 December 2008 in Transplantation
Verified
Journal Article
Closed access
JFJoana Ferrer
Joana Ferrer
WIWilliam Scott III
William Scott III
BWBradley P. Weegman
Bradley P. Weegman
TSThomas M. Suszynski
Thomas M. Suszynski
DSDavid E. R. Sutherland
David E. R. Sutherland
KPKlearchos K. Papas
Klearchos K. Papas
Background. Islet transplantation is emerging as a treatment option for selected patients with type 1 diabetes. The limited human islet supply from cadavers and poor islet yield and quality remain substantial impediments to progress in the field. Use of porcine islets holds great promise for large-scale application of islet transplantation. Consistent isolation of porcine islets is dependent on advances in pancreas procurement, pancreas preservation, and islet isolation, requiring detailed knowledge of the porcine pancreatic anatomy. The primary aim of this study was to describe the vascular and ductal anatomy of the porcine pancreas to guide and improve organ preservation and enzyme perfusion. Methods. Pancreata were removed by en bloc viscerectomy from 65 female Landrace pigs. Results. Fifteen percentage of organs exhibited inconsistent vascular branching from the celiac trunk. All organs showed uniform patterns of branching at the superior mesenteric artery. The superior and inferior mesenteric veins merged to become the portal vein in all but one case in which the inferior mesenteric vein drained into the splenic vein. Ninety-seven percent of pancreata had three lobes: duodenal lobe (DL), connecting lobe (CL), and splenic lobe (SL); 39% demonstrated ductal communication between the CL and the other two lobes; 50% had ductal communication only between the CL and duodenal lobe; and 11% presented other types of ductal delineation. Conclusions. Accounting for the variations in vascular and ductal anatomy, as detailed in this study, will facilitate development of protocols for preservation, optimal enzyme administration, and pancreas distention and digestion, and will ultimately lead to substantial improvements in isolation outcomes.

7 June 2020 in American Journal of Transplantation
Verified
Journal Article
Open access
PDF file
ETEmily R Thompson
Emily R Thompson
LBLucy Bates
Lucy Bates
IIIbrahim K Ibrahim
Ibrahim K Ibrahim
ASAvinash Sewpaul
Avinash Sewpaul
BSBen Stenberg
Ben Stenberg
CWColin H Wilson
Colin H Wilson
Ex‐vivo normothermic machine perfusion (NMP) of donor kidneys prior to transplantation provides a platform for direct delivery of cellular therapeutics to optimise organ quality prior to transplantation. Multipotent Adult Progenitor Cells (MAPC®) possess potent immunomodulatory properties which could minimise ischaemia reperfusion injury. We investigated the potential capability of MAPC cells in kidney NMP. Pairs (5) of human kidneys, from the same donor, were simultaneously perfused for 7‐hours. Kidneys were randomly allocated to receive MAPC treatment or control. Serial samples of perfusate, urine and tissue biopsies were taken for comparison. MAPC‐treated kidneys demonstrated improved urine‐output (p=0.009), decreased expression of injury biomarker NGAL (p=0.012), improved microvascular perfusion on contrast enhanced ultrasound (cortex p=0.019, medulla p=0.001), downregulation of IL‐1β (p=0.050) and upregulation of IL‐10 (p<0.047) and Indolamine‐2, 3‐dioxygenase (p=0.050). A chemotaxis model demonstrated decreased neutrophil recruitment when stimulated with perfusate from MAPC‐treated kidneys (p<0.001). Immunofluorescence revealed pre‐labelled MAPC cells in the perivascular space of kidneys during NMP. We report the first successful delivery of cellular therapy to a human kidney during NMP. Kidneys treated with MAPC cells demonstrate improvement in clinically relevant parameters and injury biomarkers. This novel method of cell therapy delivery provides an exciting opportunity to recondition organs prior to transplantation.

1 June 2012 in Cryobiology
Verified
Journal Article
Closed access
TSThomas M. Suszynski
Thomas M. Suszynski
MRMichael D. Rizzari
Michael D. Rizzari
WIWilliam Scott III
William Scott III
LTLinda A. Tempelman
Linda A. Tempelman
MTMichael J. Taylor
Michael J. Taylor
KPKlearchos K. Papas
Klearchos K. Papas

1 July 2010 in Transplantation Proceedings
Verified
Journal Article
Closed access
WIWilliam Scott III
William Scott III
BWB.P. Weegman
B.P. Weegman
JFJoana Ferrer
Joana Ferrer
SSS.A. Stein
S.A. Stein
TAT. Anazawa
T. Anazawa
KPK.K. Papas
K.K. Papas